AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed.[ Read More ]
The intrinsic value of one AXGN stock under the base case scenario is HIDDEN Compared to the current market price of 12.6 USD, AxoGen, Inc. is HIDDEN
Current Assets | 88 M |
Cash & Short-Term Investments | 37 M |
Receivables | 25.1 M |
Other Current Assets | 25.8 M |
Non-Current Assets | 109 M |
Long-Term Investments | 0 |
PP&E | 104 M |
Other Non-Current Assets | 4.53 M |
Current Liabilities | 30.4 M |
Accounts Payable | 11.8 M |
Short-Term Debt | 1.55 M |
Other Current Liabilities | 17.1 M |
Non-Current Liabilities | 70.7 M |
Long-Term Debt | 67.7 M |
Other Non-Current Liabilities | 2.99 M |
Revenue | 159 M |
Cost Of Revenue | 31.1 M |
Gross Profit | 128 M |
Operating Expenses | 149 M |
Operating Income | -21.5 M |
Other Expenses | 254 K |
Net Income | -21.7 M |
Net Income | -21.7 M |
Depreciation & Amortization | 5.55 M |
Capital Expenditures | -14.9 M |
Stock-Based Compensation | 14.4 M |
Change in Working Capital | -10.9 M |
Others | -3.97 M |
Free Cash Flow | -20.6 M |
Date | Value | Insider | Amount | Avg Price |
---|---|---|---|---|
7 months ago
Mar 21, 2024
|
Sell 24.3 K USD
|
Zaderej Karen L.
CEO |
- 3166
|
7.68 USD |
7 months ago
Mar 21, 2024
|
Sell 23.7 K USD
|
Zaderej Karen L.
CEO |
- 3086
|
7.68 USD |
7 months ago
Mar 21, 2024
|
Sell 254 K USD
|
Zaderej Karen L.
CEO |
- 33028
|
7.68 USD |
7 months ago
Mar 21, 2024
|
Sell 24.1 K USD
|
DeVinney Erick Wayne
Chief Innovation Officer |
- 3141
|
7.68 USD |
7 months ago
Mar 21, 2024
|
Sell 5.54 K USD
|
DeVinney Erick Wayne
Chief Innovation Officer |
- 721
|
7.68 USD |
7 months ago
Mar 21, 2024
|
Sell 5.5 K USD
|
DeVinney Erick Wayne
Chief Innovation Officer |
- 716
|
7.68 USD |
7 months ago
Mar 21, 2024
|
Sell 4.68 K USD
|
Scopelianos Angelo
Chief R&D Officer |
- 610
|
7.68 USD |
7 months ago
Mar 21, 2024
|
Sell 7.83 K USD
|
Scopelianos Angelo
Chief R&D Officer |
- 1020
|
7.68 USD |
7 months ago
Mar 21, 2024
|
Sell 40.3 K USD
|
Scopelianos Angelo
Chief R&D Officer |
- 5251
|
7.68 USD |
7 months ago
Mar 21, 2024
|
Sell 35.3 K USD
|
Donovan Michael Patrick
VP Operations |
- 4596
|
7.68 USD |
7 months ago
Mar 21, 2024
|
Sell 5.54 K USD
|
Donovan Michael Patrick
VP Operations |
- 721
|
7.68 USD |
7 months ago
Mar 21, 2024
|
Sell 5.5 K USD
|
Donovan Michael Patrick
VP Operations |
- 716
|
7.68 USD |
8 months ago
Mar 07, 2024
|
Sell 320 K USD
|
Donovan Michael Patrick
VP Operations |
- 36310
|
8.81 USD |
8 months ago
Mar 07, 2024
|
Sell 225 K USD
|
Freitag Gregory Gene
Director |
- 25000
|
9 USD |
11 months ago
Dec 11, 2023
|
Sell 10.6 K USD
|
MARIANI PETER J
EVP & Chief Financial Officer |
- 1410
|
7.52 USD |
11 months ago
Dec 11, 2023
|
Sell 23.4 K USD
|
MARIANI PETER J
EVP & Chief Financial Officer |
- 3120
|
7.51 USD |
11 months ago
Dec 11, 2023
|
Sell 59.8 K USD
|
MARIANI PETER J
EVP & Chief Financial Officer |
- 7970
|
7.5 USD |
1 year ago
Sep 06, 2023
|
Bought 62.2 K USD
|
Wendell Amy McBride
Director |
+ 10000
|
6.224 USD |
1 year ago
Aug 23, 2023
|
Bought 65.6 K USD
|
Burke William P. Mr.
Director |
+ 10000
|
6.56 USD |
1 year ago
Aug 16, 2023
|
Bought 61.1 K USD
|
NEELS GUIDO J
Director |
+ 10000
|
6.11 USD |
1 year ago
Jun 01, 2023
|
Sell 108 K USD
|
Freitag Gregory Gene
Director |
- 12500
|
8.65 USD |
1 year ago
Jun 01, 2023
|
Sell 258 K USD
|
Freitag Gregory Gene
Director |
- 29480
|
8.74 USD |
1 year ago
May 23, 2023
|
Sell 25.9 K USD
|
Freitag Gregory Gene
Director |
- 2828
|
9.17 USD |
1 year ago
May 23, 2023
|
Sell 43 K USD
|
Freitag Gregory Gene
Director |
- 4640
|
9.26 USD |
1 year ago
Feb 01, 2023
|
Sell 136 K USD
|
MARIANI PETER J
EVP & Chief Financial Officer |
- 14550
|
9.36 USD |
1 year ago
Jan 31, 2023
|
Sell 137 K USD
|
MARIANI PETER J
EVP & Chief Financial Officer |
- 14320
|
9.55 USD |
1 year ago
Jan 30, 2023
|
Sell 137 K USD
|
MARIANI PETER J
EVP & Chief Financial Officer |
- 14111
|
9.69 USD |
1 year ago
Jan 27, 2023
|
Sell 213 K USD
|
MARIANI PETER J
EVP & Chief Financial Officer |
- 20940
|
10.16 USD |
2 years ago
Nov 16, 2022
|
Sell 127 K USD
|
MARIANI PETER J
EVP & Chief Financial Officer |
- 10649
|
11.88 USD |
2 years ago
Nov 14, 2022
|
Sell 166 K USD
|
Freitag Gregory Gene
Director |
- 13000
|
12.74 USD |
2 years ago
Nov 08, 2022
|
Sell 162 K USD
|
Freitag Gregory Gene
Director |
- 13000
|
12.5 USD |
2 years ago
Aug 10, 2022
|
Sell 86.2 K USD
|
Freitag Gregory Gene
director: |
- 8886
|
9.696 USD |
2 years ago
Aug 04, 2022
|
Sell 255 K USD
|
Freitag Gregory Gene
Director |
- 24000
|
10.64 USD |
2 years ago
Aug 04, 2022
|
Sell 135 K USD
|
Freitag Gregory Gene
director: |
- 13046
|
10.37 USD |
3 years ago
Aug 06, 2021
|
Sell 272 K USD
|
Zaderej Karen L.
CEO |
- 14756
|
18.4 USD |
3 years ago
Aug 06, 2021
|
Sell 24.1 K USD
|
Zaderej Karen L.
CEO |
- 1259
|
19.18 USD |
3 years ago
Aug 06, 2021
|
Sell 422 K USD
|
Zaderej Karen L.
CEO |
- 22902
|
18.41 USD |
3 years ago
Aug 06, 2021
|
Sell 39.9 K USD
|
Zaderej Karen L.
CEO |
- 2083
|
19.16 USD |
3 years ago
Jul 21, 2021
|
Sell 38.8 K USD
|
Donovan Michael Patrick
VP Operations |
- 1935
|
20.04 USD |
3 years ago
Jun 04, 2021
|
Sell 50 K USD
|
MARTINEZ MARIA D.
Chief Human Resources Officer |
- 2652
|
18.86 USD |
3 years ago
Feb 25, 2021
|
Sell 529 K USD
|
Freitag Gregory Gene
Director |
- 24000
|
22.06 USD |
3 years ago
Feb 18, 2021
|
Sell 34.6 K USD
|
Donovan Michael Patrick
VP Operations |
- 1808
|
19.15 USD |
3 years ago
Jan 08, 2021
|
Sell 1.3 M USD
|
Zaderej Karen L.
CEO |
- 65000
|
20 USD |
3 years ago
Dec 30, 2020
|
Sell 30.3 K USD
|
Donovan Michael Patrick
VP Operations |
- 1733
|
17.48 USD |
3 years ago
Dec 29, 2020
|
Sell 6.61 K USD
|
DeVinney Erick Wayne
VP, Clinical&Translational Sc |
- 371
|
17.81 USD |
3 years ago
Dec 29, 2020
|
Sell 10.1 K USD
|
Donovan Michael Patrick
VP Operations |
- 567
|
17.81 USD |
3 years ago
Dec 29, 2020
|
Sell 16.3 K USD
|
Freitag Gregory Gene
Director |
- 916
|
17.81 USD |
3 years ago
Dec 29, 2020
|
Sell 23 K USD
|
MARIANI PETER J
Chief Financial Officer |
- 1293
|
17.81 USD |
3 years ago
Dec 29, 2020
|
Sell 10.1 K USD
|
Scopelianos Angelo
VP Research & Development |
- 567
|
17.81 USD |
3 years ago
Dec 29, 2020
|
Sell 62.3 K USD
|
Zaderej Karen L.
CEO |
- 3500
|
17.81 USD |
3 years ago
Dec 29, 2020
|
Sell 10.1 K USD
|
Friedman Mark Louis
VP,Regulatory & Quality |
- 567
|
17.81 USD |
3 years ago
Dec 29, 2020
|
Sell 10.1 K USD
|
MARTINEZ MARIA D.
Chief Human Resources Officer |
- 567
|
17.81 USD |
3 years ago
Dec 29, 2020
|
Sell 11.6 K USD
|
Billet Isabelle
Chief Strategy and BD Officer |
- 649
|
17.81 USD |
3 years ago
Dec 22, 2020
|
Sell 4.8 K USD
|
Donovan Michael Patrick
VP Operations |
- 279
|
17.19 USD |
3 years ago
Dec 21, 2020
|
Sell 20.9 K USD
|
Zaderej Karen L.
CEO |
- 1275
|
16.42 USD |
3 years ago
Dec 21, 2020
|
Sell 2.41 K USD
|
DeVinney Erick Wayne
VP, Clinical&Translational Sc |
- 147
|
16.42 USD |
3 years ago
Dec 21, 2020
|
Sell 6.22 K USD
|
Freitag Gregory Gene
Director |
- 379
|
16.42 USD |
3 years ago
Dec 21, 2020
|
Sell 1.58 K USD
|
Donovan Michael Patrick
VP Operations |
- 96
|
16.42 USD |
3 years ago
Dec 21, 2020
|
Sell 7.9 K USD
|
MARIANI PETER J
Chief Financial Officer |
- 481
|
16.42 USD |
3 years ago
Dec 21, 2020
|
Sell 1.58 K USD
|
Friedman Mark Louis
VP,Regulatory & Quality |
- 96
|
16.42 USD |